NCT05836324
See how this trial matches your record
Connect MyChart to see which criteria your record clearly satisfies, which need a clinician’s review, and which appear to disqualify you. Your data is read in this browser tab and never sent to our servers.
To evaluate the safety, tolerability, and DLTs and determine the MTD and/or RDE(s) of INCA33890 in participants with select advanced or metastatic solid tumors.
The Angeles Clinic and Research Institute
Los Angeles, California
Valkyrie Clinical Trials
Los Angeles, California
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China
Peking University People'S Hospital
Beijing, China
The First Affiliated Hospital, Zhejiang University School of Medicine (Fahzu)
Hangzhou, China